Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

4.215 +0.185 (+4.59%)

Streaming Delayed Price Updated: 10:30 AM EDT, Jun 4, 2026 Add to My Watchlist

Price and Volume

Volume	743,482
Open	4.050
Bid (Size)	4.210 (2,400)
Ask (Size)	4.220 (4,500)
Prev. Close	4.030
Today's Range	4.050 - 4.220
52wk Range	2.725 - 7.550
Shares Outstanding	38,886,465
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AQST Q1 2026 Earnings Call Transcript ↗

May 14, 2026

AQST Q1 2026 Earnings Call Transcript

Via The Motley Fool

Aquestive Therapeutics Q1 Earnings Call Highlights ↗

May 14, 2026

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter of...

Via MarketBeat

Performance

YTD	-34.7%	-34.7%
1 Month	-0.1%	-0.1%
3 Month	-3.5%	-3.5%
6 Month	-31.5%	-31.5%
1 Year	+32.5%	+32.5%

More News

Wondering what's happening in today's after-hours session? ↗

May 13, 2026

Via Chartmill

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

May 12, 2026

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET

May 06, 2026

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

AQST FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026

May 04, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST

May 02, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

AQUESTIVE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Large Losses They Have Until Monday May 4th to Seek Lead Plaintiff Role

May 01, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Large Losses They Have Until Monday May 4th to Seek Lead Plaintiff Role

April 29, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST

April 28, 2026

From Pomerantz LLP

Via GlobeNewswire

AQUESTIVE DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST

April 28, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until May 4th to Seek Lead Plaintiff Role

April 21, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

Robbins LLP Urges AQST Stockholders to Contact the Firm for Information About the Class Action Against Aquestive Therapeutics, Inc.

April 21, 2026

From Robbins LLP

Via Business Wire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

April 19, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)

April 14, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until May 4th to Seek Lead Plaintiff Role

April 13, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

April 09, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)

April 07, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

April 02, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026

April 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

Frequently Asked Questions

Is Aquestive Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aquestive Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aquestive Therapeutics, Inc. - Common Stock trade on?

Aquestive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aquestive Therapeutics, Inc. - Common Stock?

The ticker symbol for Aquestive Therapeutics, Inc. - Common Stock is AQST on the Nasdaq Stock Market

What is the current price of Aquestive Therapeutics, Inc. - Common Stock?

The current price of Aquestive Therapeutics, Inc. - Common Stock is 4.215

When was Aquestive Therapeutics, Inc. - Common Stock last traded?

The last trade of Aquestive Therapeutics, Inc. - Common Stock was at 06/04/26 10:30 AM ET

What is the market capitalization of Aquestive Therapeutics, Inc. - Common Stock?

The market capitalization of Aquestive Therapeutics, Inc. - Common Stock is 163.91M

How many shares of Aquestive Therapeutics, Inc. - Common Stock are outstanding?

Aquestive Therapeutics, Inc. - Common Stock has 164M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.